Switching from Human Mixtard to Humalog Mix 25: Dosing Considerations

Key Pharmacokinetic Differences

• The protamine-based formulation in Humalog Mix 25 maintains physicochemical stability and provides intermediate-acting coverage similar to NPH, though the overall duration may differ slightly from the NPH component in Mixtard 1

Recommended Transition Protocol

• Expect to adjust doses by 10-15% or 2-4 units once or twice weekly based on glucose patterns, following standard insulin titration principles 2, 3

Common Pitfalls to Avoid

• Do not mix Humalog Mix 25 with other insulins, as it is a premixed formulation designed for immediate use 4, 1